| #164 |
Rupak CHAKRABORTY |
Form Energy |
1 |
| #164 |
Arnaud Croux |
Schlumberger Technology |
1 |
| #164 |
Thomas R. Hobson |
MIT |
1 |
| #164 |
Noel Elman |
Unknown |
1 |
| #164 |
Rajendranath Selagamsetty |
Boston University |
1 |
| #164 |
Keith Michael Gabryelski |
Salesforce |
1 |
| #164 |
Gilles Besin |
Modernatx |
1 |
| #164 |
Aleksandra Rudnitskaya |
Forma Therapeutics |
1 |
| #164 |
Benjamin Hall |
Smith & Nephew |
1 |
| #164 |
Sherman Braganza |
The Mathworks |
1 |
| #164 |
Walter A. Blattler |
Immunogen |
1 |
| #164 |
Jerry Timothy Long, Jr. |
Boston Scientific Scimed |
1 |
| #164 |
Abdoulaye Ndao |
— |
1 |
| #164 |
Liam Cornell |
Dana-Farber Cancer Institute |
1 |
| #164 |
Josh Javor |
— |
1 |
| #164 |
Abraham Isaac Bassan |
Bluebird Bio |
1 |
| #164 |
Stephen Hattan |
Applied Biosystems |
1 |
| #164 |
Leah E. Cowen |
Governing Council Of The University Of Toronto |
1 |
| #164 |
Theophane Guillaume Weber |
Google |
1 |
| #164 |
Carliss Baldwin |
Silverthread |
1 |
| #164 |
Sophia Koo |
Brigham and Women's Hospital |
1 |
| #164 |
Kathleen Nudel |
Flagship Pioneering Innovations Vi |
1 |
| #164 |
Irina Gitlin |
Arsenal Medical |
1 |
| #164 |
Lucas D. BonDurant |
Alnylam Pharmaceuticals |
1 |
| #164 |
Yueyue Wang |
Toast |
1 |
| #164 |
Michael Eck |
Dana-Farber Cancer Institute |
1 |
| #164 |
Boris Kalinichenko |
Fmr |
1 |
| #164 |
Gregory S. Fischer |
Surgisense |
1 |
| #164 |
Joseph Rossi |
Bose |
1 |
| #164 |
Dilinie Fernando |
Abbott |
1 |
| #164 |
Kevin L. Ohashi |
Microvascular Tissues |
1 |
| #164 |
Anne Fortier |
Vertex Pharmaceuticals Incorporated |
1 |
| #164 |
Noah Davidsohn |
Harvard University |
1 |
| #164 |
Khashayar Kamran |
Northwestern University |
1 |
| #164 |
Rebecca Mary Chacko |
Korrus |
1 |
| #164 |
John M. Lincecum |
Als Therapy Development Institute |
1 |
| #164 |
Kilho Son |
Amazon |
1 |
| #164 |
Sava Cvek |
Stylex |
1 |
| #164 |
Wan Shou |
MIT |
1 |
| #164 |
Jerzy Olejnik |
Ambergen |
1 |
| #164 |
Jennifer Nelson |
Modernatx |
1 |
| #164 |
Cansu Demirkiran |
Lightmatter |
1 |
| #164 |
Robert Francis Fimognari |
Vertex Pharmaceuticals Incorporated |
1 |
| #164 |
Katherine Wilbur |
Rapid7 |
1 |
| #164 |
Alex Zaslavsky |
Emc Ip Holding Company |
1 |
| #164 |
Dhanesh Amarnani |
Massachusetts Eye And Ear Infirmary |
1 |
| #164 |
Merav Socolovsky |
University Of Massachusetts |
1 |
| #164 |
Chengyin Min |
Acetylon Pharmaceuticals |
1 |
| #164 |
Ruei-Zeng Lin |
— |
1 |
| #164 |
Boaz Mizrahi |
Technion Research & Development Foundation Limited |
1 |